We are live on ! Find out more
NVO

Novo Nordisk
NVO

Fund managers haven’t disclosed any holdings of NVO yet.

NVO Hedge Fund Activity: Q2 2026 in Review

1,350 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q2 2026, worth a combined $15.6B — up 26% from $12.4B a quarter earlier.

Buyers outnumbered sellers: 215 funds opened new NVO positions and 117 closed out — a net gain of 98 holders — while 464 added to existing stakes and 459 trimmed.

The largest buyer was Fred Alger Management, opening a new position worth an estimated $211M. The largest seller was Susquehanna International Group, cutting an estimated $270M.

  • 1,350 institutional investors held Novo Nordisk (NVO) as of Q2 2026, up from 1,277 in Q1 2026.
  • Funds reported $15.6B of Novo Nordisk stock for Q2 2026, up 26% quarter-over-quarter.
  • 215 funds opened new Novo Nordisk positions in Q2 2026 and 117 closed out, a net change of +98 holders.
  • The largest Novo Nordisk buyer in Q2 2026 was Fred Alger Management, an estimated $211M added.
  • The largest Novo Nordisk seller in Q2 2026 was Susquehanna International Group, an estimated $270M sold.

Based on aggregated 13F filings for Q2 2026.